
-
Voyager Therapeutics NASDAQ:VYGR Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager's wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases.
Location: 75 Sidney St, Massachusetts, 02139-4134, US | Website: www.voyagertherapeutics.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-31.39M
Cash
266.7M
Avg Qtr Burn
-3.828M
Short % of Float
6.66%
Insider Ownership
16.60%
Institutional Own.
63.44%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AAV Capsids (Pfizer) Details Neurological disorder | Phase 1 Update | |
AAV Capsids (Novartis) Details Cardiovascular disease , Neurological disorder | Phase 1 Initiation | |
AAV Capsids Details Cardiovascular disease , Neurological disorder | Phase 1 Initiation | |
AAV Capsids + ZF-TRs (Sangamo) Details Prion disease | Phase 1 Initiation | |
VY7523 (formerly VT- TAU01) [anti-tau antibody] Details Alzheimer's disease | Phase 1a Data readout | |
GBA1 gene therapy program Details Parkinson's disease, Central nervous system illness | IND Submission | |
VY-AADC (NBIb-1817) Details Parkinson's disease, Central nervous system illness | Failed Discontinued | |
VY9323 (SOD1 silencing gene therapy) Details Neurodegenerative disease, Amyotrophic lateral sclerosis | Failed Discontinued | |
VY-HTT01 Details Huntington's disease | Failed Discontinued |